Literature DB >> 28736302

Beyond PEGylation: Alternative surface-modification of nanoparticles with mucus-inert biomaterials.

Vitaliy V Khutoryanskiy1.   

Abstract

Mucus is a highly hydrated viscoelastic gel present on various moist surfaces in our body including the eyes, nasal cavity, mouth, gastrointestinal, respiratory and reproductive tracts. It serves as a very efficient barrier that prevents harmful particles, viruses and bacteria from entering the human body. However, the protective function of the mucus also hampers the diffusion of drugs and nanomedicines, which dramatically reduces their efficiency. Functionalisation of nanoparticles with low molecular weight poly(ethylene glycol) (PEGylation) is one of the strategies to enhance their penetration through mucus. Recently a number of other polymers were explored as alternatives to PEGylation. These alternatives include poly(2-alkyl-2-oxazolines), polysarcosine, poly(vinyl alcohol), other hydroxyl-containing non-ionic water-soluble polymers, zwitterionic polymers (polybetaines) and mucolytic enzymes. This review discusses the studies reporting the use of these polymers or potential application to facilitate mucus permeation of nanoparticles.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Mucoadhesion; Mucus; Mucus-penetrating nanoparticles; Poly(2-alkyl-2-oxazolines); Stealth polymers; Zwitterionic polymers

Mesh:

Substances:

Year:  2017        PMID: 28736302     DOI: 10.1016/j.addr.2017.07.015

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  24 in total

1.  Biohybrid Nanosystems for Cancer Treatment: Merging the Best of Two Worlds.

Authors:  Flavia Fontana; Raquél Bartolo; Hélder A Santos
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Nanoparticle Interactions with the Tumor Microenvironment.

Authors:  Yanyan Huai; Md Nazir Hossen; Stefan Wilhelm; Resham Bhattacharya; Priyabrata Mukherjee
Journal:  Bioconjug Chem       Date:  2019-09-05       Impact factor: 4.774

Review 3.  Nanocrystals for Improving Oral Bioavailability of Drugs: Intestinal Transport Mechanisms and Influencing Factors.

Authors:  Zonghua Tian; Yaping Mai; Tingting Meng; Shijie Ma; Guojing Gou; Jianhong Yang
Journal:  AAPS PharmSciTech       Date:  2021-06-14       Impact factor: 3.246

4.  Engineering drug delivery systems to overcome mucosal barriers for immunotherapy and vaccination.

Authors:  Jacob C McCright; Katharina Maisel
Journal:  Tissue Barriers       Date:  2019-11-28

5.  Shedding Light on the Trehalose-Enabled Mucopermeation of Nanoparticles with Label-Free Raman Spectroscopy.

Authors:  Soumik Siddhanta; Sourav Bhattacharjee; Sabine M Harrison; Dimitri Scholz; Ishan Barman
Journal:  Small       Date:  2019-07-03       Impact factor: 13.281

6.  Enabling sublingual peptide immunization with molecular self-assemblies.

Authors:  Sean H Kelly; Yaoying Wu; Ajay K Varadhan; Elizabeth J Curvino; Anita S Chong; Joel H Collier
Journal:  Biomaterials       Date:  2020-02-24       Impact factor: 12.479

Review 7.  Avoiding a Sticky Situation: Bypassing the Mucus Barrier for Improved Local Drug Delivery.

Authors:  Hannah C Zierden; Aditya Josyula; Rachel L Shapiro; Henry T Hsueh; Justin Hanes; Laura M Ensign
Journal:  Trends Mol Med       Date:  2021-01-04       Impact factor: 11.951

Review 8.  Nanomedicine for acute respiratory distress syndrome: The latest application, targeting strategy, and rational design.

Authors:  Qi Qiao; Xiong Liu; Ting Yang; Kexin Cui; Li Kong; Conglian Yang; Zhiping Zhang
Journal:  Acta Pharm Sin B       Date:  2021-05-07       Impact factor: 11.413

9.  Spatial configuration of charge and hydrophobicity tune particle transport through mucus.

Authors:  Tahoura Samad; Jacob Witten; Alan J Grodzinsky; Katharina Ribbeck
Journal:  Biophys J       Date:  2021-12-21       Impact factor: 4.033

Review 10.  Nanoparticle Delivery Systems with Cell-Specific Targeting for Pulmonary Diseases.

Authors:  Zicheng Deng; Gregory T Kalin; Donglu Shi; Vladimir V Kalinichenko
Journal:  Am J Respir Cell Mol Biol       Date:  2021-03       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.